J W van der Meer - Concepedia

Author

J W van der Meer

Also Known As

J W M van der Meer, J W Van Der Meer, J W Van der Meer, J W van der Meer, J WM van der Meer, J. W. M. van der Meer, J. W. Van der Meer, J. W. van der Meer, J.W. Van Der Meer, J.W. van der Meer

129

Publications

10.8K

Citations

H-Index

124

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center

About

J W van der Meer is an author at Radboud University Nijmegen specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	34	8.3K
2	Health Sciences	4	4	5.9K
3	Engineering	1	1	66
4	Public Health	1	1	84
5	Social Sciences	1	1	78

J W van der Meer

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis Evelina Tacconelli, Elena Carrara, Alessia Savoldi, The Lancet Infectious Diseases Bacterial ResistanceAntimicrobial Drug DiscoveryAntimicrobial SusceptibilityHealth SciencesAntibiotics	2017	5.8K
In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. Elisabeth H. Burger, J W van der Meer, Joke S. van de Gevel, The Journal of Experimental Medicine Regenerative MedicineTissue EngineeringDevelopmental BiologyMedicineBone Cultures	1982	330
Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production Joost P.H. Drenth, Stan HM van Uum, Marcel van Deuren, Journal of Applied Physiology	1995	292
Fatigue and chronic fatigue syndrome-like complaints in the general population Marjolein van't Leven, Gerhard A. Zielhuis, J W van der Meer, European Journal of Public Health	2009	242
A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection. J W van der Meer, Michael Barza, S. M. Wolff, Proceedings of the National Academy of Sciences ImmunotoxicologyLow DoseLethal Gram-negative InfectionImmune RegulationImmunology	1988	240
Prognosis in chronic fatigue syndrome: a prospective study on the natural course. Jan H. Vercoulen, C.M.A. Swanink, J.F.M. Fennis, Journal of Neurology Neurosurgery & Psychiatry	1996	215
Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome J W van der Meer European Journal of Human Genetics Periodic Fever SyndromeAutoimmune DiseaseDisease MechanismGenetic DisorderMedicine	2001	212
C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha. Seijiro Okusawa, Kim B. Yancey, J W van der Meer, The Journal of Experimental Medicine Purified C5aImmune RegulationImmunologyCell DeathPathology	1988	211
Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. Mihai G. Netea, Pierre N.M. Demacker, Bart Jan Kullberg, Journal of Clinical Investigation Microbial PathogensImmunologyPathologyControl MiceInflammation	1996	211
An open label trial of anakinra to prevent respiratory failure in COVID-19 Evdoxia Kyriazopoulou, Periklis Panagopoulos, Symeon Metallidis, eLife	2021	180

Page 1